News Wire

Health care providers in the U.S. are adopting a “better safe than sorry” approach to the current Zika virus outbreak, according to an article posted on the FierceHealthcare website. At the Cleveland Clinic in Ohio, for example, health care providers are closely watching daily updates about the…
Researchers at children’s hospitals across the U.S., including Baylor College of Medicine, the University of California–San Francisco, and the University of Colorado School of Medicine, have found that hospitals serving children may face financial penalties for patient readmissions due to factors…
Researchers have discovered that clonally expanded human immunodeficiency virus (HIV)-infected cells can persist and produce new virus over many years in patients receiving combination antiretroviral therapy (cART). Thus, any cure for HIV infection will have to attack these cells to permanently clear…
Final results for the Sunbelt melanoma trial, published online in the Journal of Clinical Oncology, show that most stage III melanoma patients do not benefit from treatment with interferon. Kelly McMasters, MD, PhD, professor and chair of the Department of Surgery at the University of Louisville, was…
Mixed results have been reported from a phase 2b trial evaluating the antidepressant activity and tolerance profile of ETS6103 (e-Therapeutics) in patients with major depressive disorder (MDD). The study evaluated ETS6103 as a potential second-line treatment for patients with MDD who do not respond…
The World Health Organization (WHO) expects suspected links between the Zika virus and two neurological disorders, microcephaly in babies and Guillain-Barre syndrome, to be confirmed within weeks, according to a report from Reuters. “We have a few more weeks to be sure to demonstrate causality, but…
The U.S. will not screen people entering the country for the Zika virus because so many of those infected do not have symptoms, the Department of Homeland Security (DHS) has announced in a published statement. “Based on our current understanding of the virus, enhanced public health entry screening…
The original version of the Centers for Medicare and Medicaid Services’ (CMS) overpayments rule required physicians to sift through 10 years of claims to make sure Medicare had not overpaid them, but now a final rule, released on February 11, requires that docs look back only six years. “Specifying…
Many cancer patients find themselves in financial distress partly because the costs of cancer-fighting drugs are skyrocketing, according to an editorial in JAMA Oncology. Is it possible to create public policy that will rein in these prices and cut patients’ out-of-pocket costs? Not without significant…
Researchers at the Yale Cancer Center have identified what causes a third of all myelomas, a type of cancer affecting plasma cells. The findings, published in the New England Journal of Medicine, could fundamentally change the way this cancer and others are treated, the researchers say. Multiple myeloma…
Positive results from a pivotal phase III study investigating the use of eribulin mesylate injection (Halaven, Eisai, Inc.) in certain types of soft-tissue sarcoma have been published online in the Lancet. The study evaluated overall survival (OS, the primary endpoint) in previously treated patients…
Incyte Corporation has announced its decision to discontinue a phase II study (JANUS 1) of ruxolitinib or placebo in combination with capecitabine for the second-line treatment of patients with advanced or metastatic pancreatic cancer. The decision to stop the study was made after a planned interim…
Researchers in the United Kingdom are working on a urine test for prostate cancer that could make invasive diagnostic procedures a thing of the past. A pilot study included 155 men presenting to urology clinics. Of this group, 58 were diagnosed with prostate cancer, 24 with bladder cancer, and 73 with…
During a recent public meeting held by the FDA’s Arthritis Advisory Committee to review the license application for CT-P13 (Celltrion), a proposed biosimilar to Remicade (infliximab, Janssen Biotech), the American College of Rheumatology (ACR) provided recommendations for policy guidelines to implement…
With a mortality rate of 0.1% and relatively few complications, 30-day readmissions represent one area in which bariatric surgery programs could improve, according to an article in the January/February 2016 issue of HealthLeaders magazine. About two-thirds of bariatric readmissions are preventable,…

Pages